Coherus Biosciences | CHRS - Marktkapitalisierung

Aktienkurs
1.81
Täglich Wechseln
0.02 1.12%
Monatlich
8.38%
Jährlich
91.29%
Q2 Prognose
1.76




Marktkapitalisierung Veränderung Datum
AbbVie USD 364.22B 20.46B 2026-05
Acadia Pharmaceuticals USD 3.77B 745M 2026-05
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 5.86B 14M 2026-05
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Baxter International USD 8.67B 1.15B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.57B 290M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Fujifilm JPY 4.03T 548.71B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
Merck USD 297.1B 35.84B 2026-03
Myriad Genetics USD 575M 98M 2025-12
Pacira USD 915M 149M 2026-03
Perrigo USD 1.58B 265M 2026-05
Pfizer USD 149.77B 4.04B 2026-05
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.04B 210M 2026-05
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Vertex Pharmaceuticals USD 111.03B 2.55B 2026-05
Xencor USD 1.09B 256M 2025-12
Zoetis USD 55.45B 9.4B 2025-12